- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Diabetes Mellitus Type 2 With Periodontal Disease in Czechia
Total 352 results
-
Institute for Clinical and Experimental MedicineCompleted
-
Charles University, Czech RepublicCompleted
-
Charles University, Czech RepublicCompletedType 2 Diabetes Mellitus With Features of Insulin ResistanceCzech Republic
-
University Hospital OstravaMinistry of Health, Czech Republic; Regional Council of the Moravian-Silesian...CompletedCritical Lower Limb Ischemia | Type-2 Diabetes MellitusCzechia
-
Institute for Clinical and Experimental MedicineUnknown
-
Charles University, Czech RepublicCompleted
-
Calliditas Therapeutics ABCompletedType 2 Diabetes Mellitus With Diabetic NephropathyAustralia, United States, Germany, Poland, Canada, Czech Republic
-
Charles University, Czech RepublicUniversity Ghent; University of Leicester; St George's, University of London; University...RecruitingPreDiabetes | Type 2 DiabetesCzechia
-
University of OstravaInstitute for Clinical and Experimental Medicine; Vitkovice HospitalActive, not recruiting
-
GT Metabolic Solutions, Inc.Recruiting
-
Institute for Clinical and Experimental MedicineRecruitingType 2 Diabetes Treated With InsulinCzechia
-
University Hospital OstravaUniversity of Ostrava; Vitkovice Hospital, Ostrava, Czech RepublicCompleted
-
University Hospital, MontpellierCompletedDiabetes Mellitus, Type 2 | Diabetes Mellitus | Diabetes Mellitus, Type 1France, Italy, Czechia
-
KeyBioscience AGNordic Bioscience A/SCompletedType 2 Diabetes MellitusDenmark, Czechia, Poland, Moldova, Republic of, Romania, United Kingdom
-
Charles University, Czech RepublicCompleted
-
Institute for Clinical and Experimental MedicineUnknownInsulin Resistance | Chronic Heart FailureCzechia
-
Institute for Clinical and Experimental MedicineCompletedInsulin Resistance | Type 2 DiabetesCzech Republic
-
Astellas Pharma IncCompleted
-
TheracosCompletedType 2 Diabetes MellitusUnited States, Japan, Czechia, Hungary, Poland, Spain
-
AstraZenecaCompletedType 2 Diabetes MellitusUnited States, Poland, Mexico, Hungary, Spain, Romania, South Africa, Denmark, Czechia, Sweden
-
Institute for Clinical and Experimental MedicineCompletedType 2 Diabetes | Postprandial Oxidative StressCzech Republic
-
Aptabio Therapeutics, Inc.CompletedDiabetes Mellitus, Type 2 | Diabetic Nephropathies | Nephropathy, DiabeticBulgaria, Czechia, Hungary, Serbia
-
Institute for Clinical and Experimental MedicineMinistry of Health, Czech RepublicCompletedInsulin Resistance | Type 2 DiabetesCzech Republic
-
Digma Medical Ltd.RecruitingDiabetes Mellitus, Type 2Israel, Czechia, Spain
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2Slovakia, Czechia
-
Charles University, Czech RepublicUnknown
-
ChemoCentryxCompletedType 2 Diabetes MellitusGermany, New Zealand, Hungary, Czechia, Australia
-
Novo Nordisk A/SCompletedHealthy | Diabetes Mellitus, Type 2 | DiabetesPoland, Slovakia, Czechia
-
Eli Lilly and CompanyCompletedType 2 Diabetes MellitusUnited States, Czechia, Puerto Rico, Poland, Mexico
-
AstraZenecaBristol-Myers SquibbCompletedType 2 Diabetes MellitusSweden, Bulgaria, Czech Republic, Hungary, Poland
-
Eli Lilly and CompanyCompletedType 2 Diabetes MellitusUnited States, Hungary, Puerto Rico, Spain, Australia, Korea, Republic of, Mexico, Japan, Germany, Russian Federation, Taiwan, Slovakia, Argentina, Czechia, India, Italy
-
Bristol-Myers SquibbCompletedType 2 Diabetes MellitusSouth Africa, United States, Canada, Puerto Rico, Hungary, Germany, Czechia, Poland, Romania, United Kingdom
-
AstraZenecaEli Lilly and CompanyCompletedType 2 Diabetes MellitusUnited States, Czech Republic, France, Korea, Republic of, Russian Federation, Spain, Mexico, Australia, Belgium, Denmark, Germany, Hungary, Netherlands, Puerto Rico, Greece, Taiwan
-
AstraZenecaEli Lilly and CompanyCompletedType 2 Diabetes MellitusAustralia, France, Italy, Korea, Republic of, Mexico, Spain, Poland, Romania, South Africa, Argentina, Austria, Belgium, Germany, Hungary, Israel, Slovakia, Greece, India, Taiwan, Canada, Czech Republic
-
AstraZenecaEli Lilly and CompanyCompletedType 2 Diabetes MellitusCzech Republic, Italy, Poland, Spain, United Kingdom, Germany, Hungary, Finland, Mexico, Austria, France, Israel, Switzerland, Ireland
-
TheracosCompletedType 2 Diabetes MellitusUnited States, Canada, Czechia, Denmark, Korea, Republic of, Mexico, Netherlands, Poland, Russian Federation, Taiwan
-
SanofiCompletedType 2 Diabetes MellitusUnited States, Argentina, Brazil, Canada, Chile, Colombia, Czech Republic, Denmark, Estonia, France, Germany, Hungary, India, Israel, Italy, Malaysia, Mexico, Netherlands, Poland, Puerto Rico, Romania, Russian Federation, South Africa, Swed... and more
-
BayerCompletedDiabetic NephropathiesHong Kong, Australia, Spain, Portugal, United States, France, Canada, Netherlands, Austria, Finland, Poland, Taiwan, Hungary, Israel, Italy, South Africa, Sweden, Bulgaria, Germany, Denmark, Czechia, Korea, Republic of, Norway
-
Eli Lilly and CompanyCompletedType 2 Diabetes MellitusCzechia, Hungary, United States, Mexico, Germany, Austria, Israel, Puerto Rico, Spain
-
AstraZenecaCompletedType 2 Diabetes Mellitus | Inadequate Glycaemic ControlUnited States, Canada, Czechia, Germany, Russian Federation, Mexico
-
Gilead SciencesCompletedType 2 Diabetes MellitusUnited States, Russian Federation, Israel, South Africa, India, Hungary, Ukraine, Canada, Czech Republic, Mexico, Poland
-
Vitadio s.r.o.University Hospital OlomoucCompletedObesity | Diabetes Mellitus, Type 2 | Insulin Resistance | Prediabetic StateCzechia
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesCzech Republic
-
AstraZenecaCompletedType 2 Diabetes Mellitus | Inadequate Glycaemic ControlGermany, Slovakia, Czechia, Hungary, Poland
-
AstraZenecaCompletedType 2 Diabetes MellitusBrazil, Italy, Korea, Republic of, Mexico, Poland, Russian Federation, South Africa, Spain, Turkey, China, Netherlands, Argentina, Austria, Czechia, United Arab Emirates, Taiwan, India, Egypt, Saudi Arabia, Lebanon, Indonesia, Col... and more
-
SanofiCompletedType 2 Diabetes MellitusUnited States, Bulgaria, Canada, Czech Republic, Denmark, Estonia, Finland, Hungary, Japan, Latvia, Lithuania, Netherlands, Puerto Rico, Romania, Slovakia, Sweden
-
Novo Nordisk A/SCompletedHeart Failure With Preserved Ejection Fraction (HFpEF) and Diabetes Mellitus, Type 2United States, Spain, Hungary, United Kingdom, India, Netherlands, Germany, Japan, Canada, Czechia, Argentina, Austria, Israel, Italy, Poland, Sweden
-
Regeneron PharmaceuticalsBayerActive, not recruitingType 2 Diabetes Mellitus | Diabetic Macular Edema | Type 1 Diabetes MellitusUnited States, Puerto Rico, Japan, United Kingdom, Canada, Czechia, Germany, Hungary
-
AstraZenecaBristol-Myers SquibbCompletedType 2 Diabetes Mellitus | Inadequate Glycaemic Control | High HbA1c LevelCzech Republic, Poland, Spain, Germany, Canada, Slovakia
-
Sankyo Pharma GmbhCompletedType 2 Diabetes Mellitus | Diabetic Nephropathy | Proteinuria | Renal DiseasePoland, Spain, Estonia, Czech Republic, Germany, Slovakia, Netherlands